MammoVerse: Clinicians Focus Group | NCT07644845

Studies
MammoVerse: Clinicians Focus Group

NCT07644845

Sponsor

University of Central Florida

Status

Enrolling by invitation

Last Update Posted

Jun 12, 2026Actual

Enrollment

12Estimated

Phase

Not provided

Conditions

Breast Cancer

Interventions

Not provided

Countries

United States

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jun 2026

Overall Recruitment Status or Expanded Access Status

Enrolling by invitation

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Feb 26, 2026Actual

Primary Completion Date

Dec 31, 2026Estimated

Completion Date

Dec 31, 2026Estimated

First Submitted Date

Jun 8, 2026

First Submission Date that Met QC Criteria

Jun 8, 2026

First Posted Date

Jun 12, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jun 8, 2026

Last Update Posted Date

Jun 12, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Clinicians will participate in virtual focus group discussions and complete a brief online demographic questionnaire. By capturing clinicians' perspectives on unmet psychosocial needs, barriers to support, and opportunities to improve patient-centered care, this study aims to inform the refinement of MammoVerse, an AI-based digital support platform intended to enhance emotional well-being, peer connection, and healthcare engagement among women facing breast cancer. This study offers preliminary data to inform the development of the MammoVerse AI platform later.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

12Estimated

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Clinician Based Focus Group to assess Emotional and Psychosocial Experiences of Women Diagnosed with Breast Cancer	This focus group study serves as the qualitative foundation for understanding the emotional and psychosocial experiences of women diagnosed with breast cancer from their clinicians' viewpoints. Insights from this exploratory work will guide future quantitative validation and the design of digital psychosocial interventions, such as AI-driven conversational tools, to provide empathetic and contextually relevant emotional support	6 months

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

they are an adult (over 18)
physician (MD or DO), licensed psychologist (PhD or PsyD), advanced practice provider (ARNP or PA), nurse (RN or LPN), licensed clinical social worker (LCSW) or other licensed clinician
provide specialized cancer care to women diagnosed with breast cancer in Florida
can provide informed consent
are self-reporting that they licensed clinicians
are self-reporting that they are physically able to participate in a 60-minute group discussion.

Exclusion Criteria:

This study will NOT include persons under the age of 18, prisoners, and persons unable to speak English fluently, and persons unable to provide informed consent. We are not able to accommodate non-English speakers as this is a pilot study involving group discussion.

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Recruitment will be through targeted outreach to clinicians providing breast cancer care in Florida. Invitations will be distributed via email to University of Central Florida College of Medicine UCF COM faculty, affiliated faculty and clinical partners over the recruitment period. Interested clinicians will be provided with study information and instructions for contacting the research team as well as accessing the online consent and enrollment materials. Interested clinicians will enroll online, and provide their information for scheduling the focus group meeting.

Sampling Method

Non-Probability Sample

ID	Term
D001943	Breast Neoplasms
D009369	Neoplasms

ID	Term
D009371	Neoplasms by Site
D001941	Breast Diseases
D012871	Skin Diseases
D017437	Skin and Connective Tissue Diseases